REG-Solvay third quarter 2026 results
Globe Newswire•04/11/2026•01:00 ET
0
Key Highlights
- ➤Q3 underlying net sales €1,031 million, down 3.3% organically year over year
- ➤Q3 underlying EBITDA €173 million, down 26.6% organically, with margin at 16.8%
- ➤2026 EBITDA guidance €720-740 million; free cash flow guidance €120-150 million
- ➤Rare earths supply agreement with Viridis secures strategic feedstock beginning in 2028
- ➤Interim dividend €0.97 gross per share approved, payable January 20, 2027
Expert Statements
Philippe Kehren, CEO of Solvay
“We continue to navigate a challenging economic environment. The conflict in the Middle East is having a significant impact on Solvay operations, with the temporary shutdown of our Peroxides plant in Jubail materially affecting the company’s short-term performance, as reflected in our updated guidance. In this context, Solvay remains focused on executing its transformation, actively managing and strengthening its portfolio to position the company for long-term growth. With our long-term supply agreement with Viridis, we strengthen our position in rare earths separation and establish a new value chain down to the customers. This is a concrete step that will allow our plant in La Rochelle to unlock future growth opportunities.”
Press release Regulated information published on November 4, 2026, at 7:00 a.m. CET
Solvay advances its strategic transformation, while navigating the challenging environment
Get started
Create a free account to read the full story.